On Friday, March 27, join two experts from Johns Hopkins Center for Health Security who will be answering your questions about what is known about the virus, how the health system is responding, how the outbreak might end and strategies for journalists to combat misinformation.
With the number of COVID-19 cases expanding exponentially, the story about the potential for treatments and vaccines remains a top priority. So does the story of drug pricing.
At a March 5 media briefing on Capitol Hill, biopharmaceutical company executives updated legislaters on potential medical countermeasures for stopping the SARS-CoV-2 virus, which causes the disease COVID-19.
As expectations grow that many more cases of COVID-19 coronavirus may be identified in the U.S. in the coming weeks, public health officials have headlined media and congressional briefings to discuss the readiness of the nation’s health system’s to respond to a surge in affected hospital patients.
In general, there is agreement that while the U.S health system is better prepared than 20 years ago, it cannot handle a sudden surge in sick patients, largely because of insufficient staff, clinical space, medical equipment and treatments. Continue reading
On New Year’s Eve, an infectious disease story emerged from China involving a mysterious pneumonia that has sickened dozens and raised alarm bells across Asia.
While the Chinese government says the outbreak, which began on Dec. 12, hasn’t resulted in any deaths, the strange illnesses are a cause of concern because China was the epicenter of SARS (severe acute respiratory syndrome) in 2003. SARS sickened 3,100 people and killed 774 in 37 countries in less than a year. Continue reading
As state legislators have grappled with policies to address vaccine hesitancy, public health officials and journalists could do more to emphasize that the United States has a well-established and effective vaccine safety surveillance system, policy experts told AHCJ members during a Nov. 21 webcast.
The U.S. engages several agencies and organizations, including the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, the Health Resources and Services Administration, and the National Academy of Medicine, plus eight health care systems and seven academic hospitals in monitoring vaccine safety. Continue reading
As public health officials grapple with strategies to respond to natural disasters and disease outbreaks, they face a host of challenges, from misinformation on social media and some communities’ lack of trust in government to the definition of what being “prepared” means.
That is why engaging with community leaders on emergency preparedness is especially important, two public health leaders told AHCJ members in a recent webcast. Continue reading